Global and United States Antiretroviral Therapy Market Insights, Forecast to 2027

Publisher Name :
Date: 12-Aug-2021
No. of pages: 130
Inquire Before Buying

Antiretroviral Therapy market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Antiretroviral Therapy market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- NNRTIs

- NRTI

- Multiclass Combination Products

- Integrase Inhibitors

Segment by Application

- Hospital

- Clinic

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Gilead

- F. Hoffmann-La Roche

- ViiV Healthcare

- Boehringer Ingelheim

- Janssen Pharmaceuticals

- Mylan

- Abbvie

- Bionor Pharma

- Vertex Pharmaceuticals

Global and United States Antiretroviral Therapy Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Antiretroviral Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Antiretroviral Therapy Market Size Growth Rate by Type
1.2.2 NNRTIs
1.2.3 NRTI
1.2.4 Multiclass Combination Products
1.2.5 Integrase Inhibitors
1.3 Market by Application
1.3.1 Global Antiretroviral Therapy Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antiretroviral Therapy Market Size, Estimates and Forecasts
2.1.1 Global Antiretroviral Therapy Revenue 2016-2027
2.1.2 Global Antiretroviral Therapy Sales 2016-2027
2.2 Global Antiretroviral Therapy, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Antiretroviral Therapy Historical Market Size by Region (2016-2021)
2.3.1 Global Antiretroviral Therapy Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Antiretroviral Therapy Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Antiretroviral Therapy Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Antiretroviral Therapy Sales Forecast by Region (2022-2027)
2.4.2 Global Antiretroviral Therapy Revenue Forecast by Region (2022-2027)
3 Global Antiretroviral Therapy Competitor Landscape by Players
3.1 Global Top Antiretroviral Therapy Manufacturers by Sales
3.1.1 Global Antiretroviral Therapy Sales by Manufacturer (2016-2021)
3.1.2 Global Antiretroviral Therapy Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Antiretroviral Therapy Manufacturers by Revenue
3.2.1 Key Antiretroviral Therapy Manufacturers Covered: Ranking by Revenue
3.2.2 Global Antiretroviral Therapy Revenue by Manufacturers (2016-2021)
3.2.3 Global Antiretroviral Therapy Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Antiretroviral Therapy Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Antiretroviral Therapy Revenue in 2020
3.2.6 Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antiretroviral Therapy Price by Manufacturers
3.4 Global Antiretroviral Therapy Manufacturing Base Distribution, Product Types
3.4.1 Antiretroviral Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antiretroviral Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Antiretroviral Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Antiretroviral Therapy Market Size by Type (2016-2021)
4.1.1 Global Antiretroviral Therapy Sales by Type (2016-2021)
4.1.2 Global Antiretroviral Therapy Revenue by Type (2016-2021)
4.1.3 Antiretroviral Therapy Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Antiretroviral Therapy Market Size Forecast by Type (2022-2027)
4.2.1 Global Antiretroviral Therapy Sales Forecast by Type (2022-2027)
4.2.2 Global Antiretroviral Therapy Revenue Forecast by Type (2022-2027)
4.2.3 Antiretroviral Therapy Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Antiretroviral Therapy Market Size by Application (2016-2021)
5.1.1 Global Antiretroviral Therapy Sales by Application (2016-2021)
5.1.2 Global Antiretroviral Therapy Revenue by Application (2016-2021)
5.1.3 Antiretroviral Therapy Price by Application (2016-2021)
5.2 Antiretroviral Therapy Market Size Forecast by Application (2022-2027)
5.2.1 Global Antiretroviral Therapy Sales Forecast by Application (2022-2027)
5.2.2 Global Antiretroviral Therapy Revenue Forecast by Application (2022-2027)
5.2.3 Global Antiretroviral Therapy Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Antiretroviral Therapy Market Size YoY Growth 2016-2027
6.1.1 United States Antiretroviral Therapy Sales YoY Growth 2016-2027
6.1.2 United States Antiretroviral Therapy Revenue YoY Growth 2016-2027
6.1.3 United States Antiretroviral Therapy Market Share in Global Market 2016-2027
6.2 United States Antiretroviral Therapy Market Size by Players (International and Local Players)
6.2.1 United States Top Antiretroviral Therapy Players by Sales (2016-2021)
6.2.2 United States Top Antiretroviral Therapy Players by Revenue (2016-2021)
6.3 United States Antiretroviral Therapy Historic Market Review by Type (2016-2021)
6.3.1 United States Antiretroviral Therapy Sales Market Share by Type (2016-2021)
6.3.2 United States Antiretroviral Therapy Revenue Market Share by Type (2016-2021)
6.3.3 United States Antiretroviral Therapy Price by Type (2016-2021)
6.4 United States Antiretroviral Therapy Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Antiretroviral Therapy Sales Forecast by Type (2022-2027)
6.4.2 United States Antiretroviral Therapy Revenue Forecast by Type (2022-2027)
6.4.3 United States Antiretroviral Therapy Price Forecast by Type (2022-2027)
6.5 United States Antiretroviral Therapy Historic Market Review by Application (2016-2021)
6.5.1 United States Antiretroviral Therapy Sales Market Share by Application (2016-2021)
6.5.2 United States Antiretroviral Therapy Revenue Market Share by Application (2016-2021)
6.5.3 United States Antiretroviral Therapy Price by Application (2016-2021)
6.6 United States Antiretroviral Therapy Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Antiretroviral Therapy Sales Forecast by Application (2022-2027)
6.6.2 United States Antiretroviral Therapy Revenue Forecast by Application (2022-2027)
6.6.3 United States Antiretroviral Therapy Price Forecast by Application (2022-2027)
7 North America
7.1 North America Antiretroviral Therapy Market Size YoY Growth 2016-2027
7.2 North America Antiretroviral Therapy Market Facts & Figures by Country
7.2.1 North America Antiretroviral Therapy Sales by Country (2016-2021)
7.2.2 North America Antiretroviral Therapy Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Antiretroviral Therapy Market Size YoY Growth 2016-2027
8.2 Asia Pacific Antiretroviral Therapy Market Facts & Figures by Region
8.2.1 Asia Pacific Antiretroviral Therapy Sales by Region (2016-2021)
8.2.2 Asia Pacific Antiretroviral Therapy Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Antiretroviral Therapy Market Size YoY Growth 2016-2027
9.2 Europe Antiretroviral Therapy Market Facts & Figures by Country
9.2.1 Europe Antiretroviral Therapy Sales by Country (2016-2021)
9.2.2 Europe Antiretroviral Therapy Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Antiretroviral Therapy Market Size YoY Growth 2016-2027
10.2 Latin America Antiretroviral Therapy Market Facts & Figures by Country
10.2.1 Latin America Antiretroviral Therapy Sales by Country (2016-2021)
10.2.2 Latin America Antiretroviral Therapy Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antiretroviral Therapy Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Antiretroviral Therapy Market Facts & Figures by Country
11.2.1 Middle East and Africa Antiretroviral Therapy Sales by Country (2016-2021)
11.2.2 Middle East and Africa Antiretroviral Therapy Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Gilead
12.1.1 Gilead Corporation Information
12.1.2 Gilead Description and Business Overview
12.1.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Antiretroviral Therapy Products Offered
12.1.5 Gilead Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Corporation Information
12.2.2 F. Hoffmann-La Roche Description and Business Overview
12.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products Offered
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 ViiV Healthcare
12.3.1 ViiV Healthcare Corporation Information
12.3.2 ViiV Healthcare Description and Business Overview
12.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.3.4 ViiV Healthcare Antiretroviral Therapy Products Offered
12.3.5 ViiV Healthcare Recent Development
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Corporation Information
12.4.2 Boehringer Ingelheim Description and Business Overview
12.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Boehringer Ingelheim Antiretroviral Therapy Products Offered
12.4.5 Boehringer Ingelheim Recent Development
12.5 Janssen Pharmaceuticals
12.5.1 Janssen Pharmaceuticals Corporation Information
12.5.2 Janssen Pharmaceuticals Description and Business Overview
12.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products Offered
12.5.5 Janssen Pharmaceuticals Recent Development
12.6 Mylan
12.6.1 Mylan Corporation Information
12.6.2 Mylan Description and Business Overview
12.6.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Mylan Antiretroviral Therapy Products Offered
12.6.5 Mylan Recent Development
12.7 Abbvie
12.7.1 Abbvie Corporation Information
12.7.2 Abbvie Description and Business Overview
12.7.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbvie Antiretroviral Therapy Products Offered
12.7.5 Abbvie Recent Development
12.8 Bionor Pharma
12.8.1 Bionor Pharma Corporation Information
12.8.2 Bionor Pharma Description and Business Overview
12.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bionor Pharma Antiretroviral Therapy Products Offered
12.8.5 Bionor Pharma Recent Development
12.9 Vertex Pharmaceuticals
12.9.1 Vertex Pharmaceuticals Corporation Information
12.9.2 Vertex Pharmaceuticals Description and Business Overview
12.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products Offered
12.9.5 Vertex Pharmaceuticals Recent Development
12.11 Gilead
12.11.1 Gilead Corporation Information
12.11.2 Gilead Description and Business Overview
12.11.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Gilead Antiretroviral Therapy Products Offered
12.11.5 Gilead Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Antiretroviral Therapy Industry Trends
13.2 Antiretroviral Therapy Market Drivers
13.3 Antiretroviral Therapy Market Challenges
13.4 Antiretroviral Therapy Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antiretroviral Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Antiretroviral Therapy Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of NNRTIs
Table 3. Major Manufacturers of NRTI
Table 4. Major Manufacturers of Multiclass Combination Products
Table 5. Major Manufacturers of Integrase Inhibitors
Table 6. Global Antiretroviral Therapy Market Size Growth Rate by Application (2021-2027) & (KG)
Table 7. Global Antiretroviral Therapy Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Antiretroviral Therapy Sales by Regions (2016-2021) & (KG)
Table 9. Global Antiretroviral Therapy Sales Market Share by Regions (2016-2021)
Table 10. Global Antiretroviral Therapy Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Antiretroviral Therapy Sales Forecast by Region (2022-2027) & (KG)
Table 12. Global Antiretroviral Therapy Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Antiretroviral Therapy Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Antiretroviral Therapy Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Antiretroviral Therapy Sales by Manufacturers (2016-2021) (KG)
Table 16. Global Antiretroviral Therapy Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Antiretroviral Therapy Manufacturers by Revenue (US$ Million) in 2020
Table 18. Antiretroviral Therapy Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Antiretroviral Therapy Revenue Share by Manufacturers (2016-2021)
Table 20. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Antiretroviral Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Therapy as of 2020)
Table 22. Key Manufacturers Antiretroviral Therapy Price (2016-2021) (USD/KG)
Table 23. Antiretroviral Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antiretroviral Therapy Product Type
Table 25. Date of International Manufacturers Enter into Antiretroviral Therapy Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Antiretroviral Therapy Sales by Type (2016-2021) (KG)
Table 28. Global Antiretroviral Therapy Sales Share by Type (2016-2021)
Table 29. Global Antiretroviral Therapy Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Antiretroviral Therapy Revenue Share by Type (2016-2021)
Table 31. Antiretroviral Therapy Average Selling Price (ASP) by Type (2016-2021) & (USD/KG)
Table 32. Global Antiretroviral Therapy Sales Forecast by Type (2022-2027) & (KG)
Table 33. Global Antiretroviral Therapy Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Antiretroviral Therapy Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Antiretroviral Therapy Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Antiretroviral Therapy Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/KG)
Table 37. Global Antiretroviral Therapy Sales by Application (2016-2021) (KG)
Table 38. Global Antiretroviral Therapy Sales Share by Application (2016-2021)
Table 39. Global Antiretroviral Therapy Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Antiretroviral Therapy Revenue Share by Application (2016-2021)
Table 41. Antiretroviral Therapy Average Selling Price (ASP) by Application (2016-2021) & (USD/KG)
Table 42. Global Antiretroviral Therapy Sales Forecast by Application (2022-2027) & (KG)
Table 43. Global Antiretroviral Therapy Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Antiretroviral Therapy Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Antiretroviral Therapy Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Antiretroviral Therapy Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/KG)
Table 47. United States Antiretroviral Therapy Sales (KG) of Key Companies (2016-2021)
Table 48. United States Antiretroviral Therapy Sales Share by Company (2016-2021)
Table 49. United States Antiretroviral Therapy Revenue (US$ Million) by Company (2016-2021)
Table 50. United States Antiretroviral Therapy Revenue Share by Company (2016-2021)
Table 51. United States Antiretroviral Therapy Sales (KG) by Type (2016-2021)
Table 52. United States Antiretroviral Therapy Sales Share by Type (2016-2021)
Table 53. United States Antiretroviral Therapy Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. United States Antiretroviral Therapy Price (USD/KG) by Type (2016-2021)
Table 55. United States Antiretroviral Therapy Sales (KG) by Type (2022-2027)
Table 56. United States Antiretroviral Therapy Sales Share by Type (2022-2027)
Table 57. United States Antiretroviral Therapy Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. United States Antiretroviral Therapy Revenue Share by Type (2022-2027)
Table 59. United States Antiretroviral Therapy Price (USD/KG) by Type (2022-2027)
Table 60. United States Antiretroviral Therapy Sales (KG) by Application (2016-2021)
Table 61. United States Antiretroviral Therapy Sales Share by Application (2016-2021)
Table 62. United States Antiretroviral Therapy Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. United States Antiretroviral Therapy Price (USD/KG) by Application (2016-2021)
Table 64. United States Antiretroviral Therapy Sales (KG) by Application (2022-2027)
Table 65. United States Antiretroviral Therapy Sales Share by Application (2022-2027)
Table 66. United States Antiretroviral Therapy Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. United States Antiretroviral Therapy Revenue Share by Application (2022-2027)
Table 68. United States Antiretroviral Therapy Price (USD/KG) by Application (2022-2027)
Table 69. North America Antiretroviral Therapy Sales by Country (2016-2021) & (KG)
Table 70. North America Antiretroviral Therapy Sales Market Share by Country (2016-2021)
Table 71. North America Antiretroviral Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Antiretroviral Therapy Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Antiretroviral Therapy Sales by Region (2016-2021) & (KG)
Table 74. Asia Pacific Antiretroviral Therapy Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Antiretroviral Therapy Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Antiretroviral Therapy Revenue Market Share by Region (2016-2021)
Table 77. Europe Antiretroviral Therapy Sales by Country (2016-2021) & (KG)
Table 78. Europe Antiretroviral Therapy Sales Market Share by Country (2016-2021)
Table 79. Europe Antiretroviral Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Antiretroviral Therapy Revenue Market Share by Country (2016-2021)
Table 81. Latin America Antiretroviral Therapy Sales by Country (2016-2021) & (KG)
Table 82. Latin America Antiretroviral Therapy Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Antiretroviral Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Antiretroviral Therapy Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Antiretroviral Therapy Sales by Country (2016-2021) & (KG)
Table 86. Middle East and Africa Antiretroviral Therapy Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Antiretroviral Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Antiretroviral Therapy Revenue Market Share by Country (2016-2021)
Table 89. Gilead Corporation Information
Table 90. Gilead Description and Business Overview
Table 91. Gilead Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 92. Gilead Antiretroviral Therapy Product
Table 93. Gilead Recent Development
Table 94. F. Hoffmann-La Roche Corporation Information
Table 95. F. Hoffmann-La Roche Description and Business Overview
Table 96. F. Hoffmann-La Roche Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 97. F. Hoffmann-La Roche Product
Table 98. F. Hoffmann-La Roche Recent Development
Table 99. ViiV Healthcare Corporation Information
Table 100. ViiV Healthcare Description and Business Overview
Table 101. ViiV Healthcare Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 102. ViiV Healthcare Product
Table 103. ViiV Healthcare Recent Development
Table 104. Boehringer Ingelheim Corporation Information
Table 105. Boehringer Ingelheim Description and Business Overview
Table 106. Boehringer Ingelheim Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 107. Boehringer Ingelheim Product
Table 108. Boehringer Ingelheim Recent Development
Table 109. Janssen Pharmaceuticals Corporation Information
Table 110. Janssen Pharmaceuticals Description and Business Overview
Table 111. Janssen Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 112. Janssen Pharmaceuticals Product
Table 113. Janssen Pharmaceuticals Recent Development
Table 114. Mylan Corporation Information
Table 115. Mylan Description and Business Overview
Table 116. Mylan Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 117. Mylan Product
Table 118. Mylan Recent Development
Table 119. Abbvie Corporation Information
Table 120. Abbvie Description and Business Overview
Table 121. Abbvie Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 122. Abbvie Product
Table 123. Abbvie Recent Development
Table 124. Bionor Pharma Corporation Information
Table 125. Bionor Pharma Description and Business Overview
Table 126. Bionor Pharma Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 127. Bionor Pharma Product
Table 128. Bionor Pharma Recent Development
Table 129. Vertex Pharmaceuticals Corporation Information
Table 130. Vertex Pharmaceuticals Description and Business Overview
Table 131. Vertex Pharmaceuticals Antiretroviral Therapy Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2016-2021)
Table 132. Vertex Pharmaceuticals Product
Table 133. Vertex Pharmaceuticals Recent Development
Table 134. Antiretroviral Therapy Market Trends
Table 135. Antiretroviral Therapy Market Drivers
Table 136. Antiretroviral Therapy Market Challenges
Table 137. Antiretroviral Therapy Market Restraints
Table 138. Antiretroviral Therapy Customers List
Table 139. Antiretroviral Therapy Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Sales Market Share by Type in 2020 & 2027
Figure 3. NNRTIs Product Picture
Figure 4. NRTI Product Picture
Figure 5. Multiclass Combination Products Product Picture
Figure 6. Integrase Inhibitors Product Picture
Figure 7. Global Antiretroviral Therapy Sales Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Antiretroviral Therapy Report Years Considered
Figure 12. Global Antiretroviral Therapy Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antiretroviral Therapy Market Size 2016-2027 (US$ Million)
Figure 14. Global Antiretroviral Therapy Sales 2016-2027 (KG)
Figure 15. Global Antiretroviral Therapy Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Antiretroviral Therapy Sales Market Share by Region (2016-2021)
Figure 17. Global Antiretroviral Therapy Sales Market Share by Region in 2020
Figure 18. Global Antiretroviral Therapy Revenue Market Share by Region (2016-2021)
Figure 19. Global Antiretroviral Therapy Revenue Market Share by Region in 2020
Figure 20. Global Antiretroviral Therapy Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Antiretroviral Therapy Revenue in 2020
Figure 22. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Antiretroviral Therapy Sales Market Share by Type (2016-2021)
Figure 24. Global Antiretroviral Therapy Sales Market Share by Type in 2020
Figure 25. Global Antiretroviral Therapy Revenue Market Share by Type (2016-2021)
Figure 26. Global Antiretroviral Therapy Revenue Market Share by Type in 2020
Figure 27. Global Antiretroviral Therapy Sales Market Share by Application (2016-2021)
Figure 28. Global Antiretroviral Therapy Sales Market Share by Application in 2020
Figure 29. Global Antiretroviral Therapy Revenue Market Share by Application (2016-2021)
Figure 30. Global Antiretroviral Therapy Revenue Market Share by Application in 2020
Figure 31. United States Antiretroviral Therapy Sales Growth Rate 2016-2027 (KG)
Figure 32. United States Antiretroviral Therapy Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. United States Antiretroviral Therapy Market Share in Global Market 2016-2027
Figure 34. United States 5 and 10 Largest Antiretroviral Therapy Players Market Share by Revenue in Antiretroviral Therapy in 2020
Figure 35. United States Antiretroviral Therapy Revenue Share by Type (2016-2021)
Figure 36. United States Antiretroviral Therapy Revenue Growth Rate by Type in 2016 & 2020
Figure 37. United States Antiretroviral Therapy Revenue Share by Application (2016-2021)
Figure 38. United States Antiretroviral Therapy Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Antiretroviral Therapy Sales Growth Rate 2016-2021 (KG)
Figure 40. North America Antiretroviral Therapy Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Antiretroviral Therapy Sales Market Share by Country in 2020
Figure 42. North America Antiretroviral Therapy Revenue Market Share by Country in 2020
Figure 43. U.S. Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 44. U.S. Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 46. Canada Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Antiretroviral Therapy Sales Growth Rate 2016-2021 (KG)
Figure 48. Europe Antiretroviral Therapy Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Antiretroviral Therapy Sales Market Share by Country in 2020
Figure 50. Europe Antiretroviral Therapy Revenue Market Share by Country in 2020
Figure 51. Germany Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 52. Germany Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 54. France Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 56. U.K. Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 58. Italy Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 60. Russia Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Antiretroviral Therapy Sales Growth Rate 2016-2021 (KG)
Figure 62. Asia Pacific Antiretroviral Therapy Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Antiretroviral Therapy Sales Market Share by Region in 2020
Figure 64. Asia Pacific Antiretroviral Therapy Revenue Market Share by Region in 2020
Figure 65. China Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 66. China Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 68. Japan Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 70. South Korea Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 72. India Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Australia Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 74. Australia Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. China Taiwan Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 76. China Taiwan Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 78. Indonesia Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 80. Thailand Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 82. Malaysia Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Latin America Antiretroviral Therapy Sales Growth Rate 2016-2021 (KG)
Figure 84. Latin America Antiretroviral Therapy Revenue Growth Rate 2016-2021 (US$ Million)
Figure 85. Latin America Antiretroviral Therapy Sales Market Share by Country in 2020
Figure 86. Latin America Antiretroviral Therapy Revenue Market Share by Country in 2020
Figure 87. Mexico Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 88. Mexico Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Brazil Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 90. Brazil Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Argentina Antiretroviral Therapy Sales Growth Rate (2016-2021) (KG)
Figure 92. Argentina Antiretroviral Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Middle East and Africa Antiretroviral Therapy Sales Growth Rate 2016-2021 (KG)
Figure 94. Middle East and Africa Antiretroviral Therapy Revenue Growth Rate 2016-2021 (US$ Million)
Figure 95. Middle East and Africa Antiretroviral Therapy Sales Market Share by Country in 2020
Figure 96. Middle East and Africa Antiretroviral Therapy Revenue Market Share by Country in 2020
  • Global Antiretroviral Therapy Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antiretroviral Therapy market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Gilead - F. Hoffmann-La Roche - ViiV Healthcare - Boehringer Ingelheim - Janssen Pharmaceuticals - Mylan - Abbvie - Bionor Pharma......
  • Global Antiretroviral Therapy Professional Survey Report 2023, Forecast to 2028
    Published: 22-Mar-2023        Price: US 3280 Onwards        Pages: 108
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Antiretroviral Therapy Market Research Report 2023, Forecast to 2028
    Published: 22-Mar-2023        Price: US 2680 Onwards        Pages: 131
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Antiretroviral Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 21-Sep-2022        Price: US 5600 Onwards        Pages: 104
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antiretroviral Therapy manufacturers, distributors, end users, industry associations, governments' industry bureaus, indust......
  • Global Antiretroviral Therapy Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
    Published: 31-Jul-2022        Price: US 3480 Onwards        Pages: 96
    The Antiretroviral Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our (Global I......
  • Global Antiretroviral Therapy Market Insights and Forecast to 2028
    Published: 07-Apr-2022        Price: US 4900 Onwards        Pages: 89
    Antiretroviral Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors ......
  • United States Antiretroviral Therapy Market Report & Forecast 2021-2027
    Published: 25-Nov-2021        Price: US 3400 Onwards        Pages: 93
    United States Antiretroviral Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (KG) United States Antiretroviral Therapy Market Segment Percentages, By Type, 2020 (%) - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors United States Antiretroviral Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (KG) United States Antiretroviral Therapy Market Segment Percentages, By Application, 2020 (%)......
  • China Antiretroviral Therapy Market Report & Forecast 2021-2027
    Published: 03-Nov-2021        Price: US 3400 Onwards        Pages: 91
    China Antiretroviral Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (KG) China Antiretroviral Therapy Market Segment Percentages, By Type, 2020 (%) - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors China Antiretroviral Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (KG) China Antiretroviral Therapy Market Segment Percentages, By Application, 2020 (%) - Hospital - Clini......
  • Global and United States Antiretroviral Therapy Market Insights, Forecast to 2027
    Published: 12-Aug-2021        Price: US 3900 Onwards        Pages: 130
    Antiretroviral Therapy market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Ant......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs